Comparison between PACAP- and enriched environment-induced retinal protection in MSG-treated newborn rats
- PMID: 21050880
- DOI: 10.1016/j.neulet.2010.10.065
Comparison between PACAP- and enriched environment-induced retinal protection in MSG-treated newborn rats
Abstract
Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors occur throughout the nervous system, including the retina. PACAP exerts diverse actions in the eye: it influences ocular blood flow, contraction of the ciliary muscle, and has retinoprotective effects. This effect has been proven in different models of retinal degeneration. We have previously shown that PACAP protects against monosodium-glutamate (MSG)-induced damage in neonatal rats. The beneficial effects of enriched environment, another neuroprotective strategy, have long been known. Environmental enrichment has been shown to decrease different neuronal injuries. It also influences the development of the visual system. We have recently demonstrated that significant neuroprotection can be achieved in MSG-induced retinal degeneration in animals kept in an enriched environment. Combination of neuroprotective strategies often results in increased protection. Therefore, the aim of the present study was to compare the two neuroprotective strategies alone and in combination therapy. We found that both PACAP and environmental enrichment led to a similar degree of retinal protection, but the two treatments together did not lead to increased protection: their effects were not additive.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.Neurosci Lett. 2004 Nov 30;372(1-2):110-3. doi: 10.1016/j.neulet.2004.09.021. Neurosci Lett. 2004. PMID: 15531098
-
Early postnatal enriched environment decreases retinal degeneration induced by monosodium glutamate treatment in rats.Brain Res. 2009 Mar 9;1259:107-12. doi: 10.1016/j.brainres.2009.01.004. Epub 2009 Jan 10. Brain Res. 2009. PMID: 19171125
-
The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways.Regul Pept. 2006 Nov 15;137(1-2):20-6. doi: 10.1016/j.regpep.2006.02.009. Epub 2006 Aug 30. Regul Pept. 2006. PMID: 16945433
-
Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.Ann N Y Acad Sci. 2010 Jul;1200:128-39. doi: 10.1111/j.1749-6632.2010.05512.x. Ann N Y Acad Sci. 2010. PMID: 20633141 Review.
-
Alternative Routes of Administration of the Neuroprotective Pituitary Adenylate Cyclase Activating Polypeptide.Curr Pharm Des. 2018;24(33):3892-3904. doi: 10.2174/1381612824666181112110934. Curr Pharm Des. 2018. PMID: 30417775 Review.
Cited by
-
Gender-dependent effects of enriched environment and social isolation in ischemic retinal lesion in adult rats.Int J Mol Sci. 2013 Aug 5;14(8):16111-23. doi: 10.3390/ijms140816111. Int J Mol Sci. 2013. PMID: 23921682 Free PMC article.
-
Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents.Int J Mol Sci. 2017 Mar 21;18(3):675. doi: 10.3390/ijms18030675. Int J Mol Sci. 2017. PMID: 28335564 Free PMC article.
-
Neuropeptides and diabetic retinopathy.Br J Clin Pharmacol. 2013 May;75(5):1189-201. doi: 10.1111/bcp.12003. Br J Clin Pharmacol. 2013. PMID: 23043302 Free PMC article. Review.
-
Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin.Front Neurosci. 2019 Oct 9;13:1031. doi: 10.3389/fnins.2019.01031. eCollection 2019. Front Neurosci. 2019. PMID: 31649495 Free PMC article. Review.
-
PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.J Mol Neurosci. 2016 Oct;60(2):179-85. doi: 10.1007/s12031-016-0797-5. Epub 2016 Aug 25. J Mol Neurosci. 2016. PMID: 27561927
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources